AbbVie (ABBV) Beats Q2 Earnings and Revenue Estimates
AbbVie (ABBV) delivered earnings and revenue surprises of 4.30% and 2.54%, respectively, for the quarter ended June 2023. Do the…
170,370$
-0,67%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
Inside AbbVie: Signs of stabilization in Humira sales?
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Boosts FY23 Outlook As Q2 Results Top Estimates
WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Thursday, biopharmaceutical company AbbVie, Inc. (ABBV) trimmed its…
AbbVie Q2 Profit Increases, beats estimates
WASHINGTON (dpa-AFX) - AbbVie (ABBV) released a profit for its second quarter that increased from last year and beat the…
AbbVie shares climb after quarterly results beat expectations
AbbVie Inc. ABBV shares gained 1.5% premarket on Thursday after the pharmaceutical giant reported stronger-than-expected revenue for the second quarter…
Form 8-K AbbVie Inc. For: Jul 27
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie raises annual profit forecast as Humira stays strong, new drugs impress
...(Reuters) - AbbVie on Thursday raised its annual profit forecast......…
AbbVie Non-GAAP EPS of $2.91 beats by $0.10, revenue of $13.87B beats by $350M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
PREVIEW-AbbVie may see less pain from Humira sales decline as rival lags
...By Leroy Leo
July 26 (Reuters) - AbbVie Inc is likely to
beat Wall......…
AbbVie may see less pain from Humira sales decline as rival lags
...By Leroy Leo
(Reuters) - AbbVie Inc is likely to beat Wall......…
AbbVie under pressure ahead of Q2 results amid Humira cliff
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie expands collaboration with Calibr on early-stage assets
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries
Seven pharmaceutical companies recently launched their biosimilars of AbbVie Inc's (NYSE: ABBV) top-selling read more...…
The Zacks Analyst Blog Highlights Toyota, Deere, Starbucks, AbbVie and DexCom
Toyota, Deere, Starbucks, AbbVie and DexCom are included in this Analyst Blog....…
Earnings Previews: AbbVie, Comcast, Valero Energy
Before U.S. markets open on Thursday, these three firms will be reporting quarterly results....…
AbbVie turns to newer immunology drugs as blockbuster Humira faces lower-cost competition
Investors look for signs that Skyrizi, Rinvoq can take the baton as Humira sales falter...…
Zacks Investment Ideas feature highlights: Chipotle Mexican Grill, Visa and AbbVie
Chipotle Mexican Grill, Visa and AbbVie have been highlighted in this Investment Ideas article....…
AbbVie wins EU backing for Genmab-partnered lymphoma therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Company Announcement...…
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $137.68, moving +0.81% from the previous trading session....…
The Zacks Analyst Blog Highlights Walmart, AbbVie, Nike, Uber and PayPal
Walmart, AbbVie, Nike, Uber and PayPal are included in this Analyst Blog....…
Top Analyst Reports for Walmart, AbbVie & Nike
Todays Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), AbbVie Inc. (ABBV) and Nike,…
AbbVie slips as Cigna adds more Humira biosimilars for coverage
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dividend Roundup: Unilever, PNC Financial, Oracle, AbbVie, and more
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie updates full-year EPS estimate range; below consensus
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
UPDATE 1-AbbVie trims full-year profit forecast on higher R&D expenses
...(Adds second quarter forecast in paragraph 5)
July 6 (Reuters......…
AbbVie trims full-year profit forecast due to higher R&D expenses
...(Reuters) - AbbVie Inc cut full-year profit forecast due......…
Form 8-K AbbVie Inc. For: Jul 06
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie to Host Second-Quarter 2023 Earnings Conference Call
NORTH CHICAGO, Ill., July 6, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2023 financial results on Thursday,…
AbbVie braces for increased Humira competition from cheaper ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
CollPlant reaches milestone in collagen agreement with AbbVie
The milestone triggers a $10 million payment to CollPlant, which is also collaborating with Stratasys on 3D-printed tissue....…
Could This New Drug Be a Blockbuster for These 2 Pharma Collaborators?
In May, the FDA approved epcoritamab, developed by AbbVie and Genmab, as a treatment for a type of blood cancer....…
This Is What Whales Are Betting On AbbVie
read more...…
Cheaper competition for Humira is hitting the market, but savings will depend on your insurance
Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the…
AbbVie president given added COO duties
AbbVie Inc. ABBV said late Thursday its vice chairman and president will take on the added role of chief operating…
Robert Michael named president and COO at AbbVie - filing
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AbbVie Inc. For: Jun 29
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…